Fulgent Genetics, Inc. provided earnings guidance for the year 2024. For the year, The company expects total core revenues to be approximately $280 million for 2024, representing a core growth of 7% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 USD | +1.22% | +6.97% | -25.63% |
May. 03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.63% | 643M | |
-18.58% | 8.3B | |
-8.58% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.31B | |
-5.44% | 1.95B | |
-17.79% | 1.59B | |
-40.78% | 1.21B | |
+6.69% | 1.1B | |
-23.31% | 931M |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024